Boston Scientific's Watchman device could soon face its first domestic competitor if Abbott's Amulet is approved by FDA in the second half as expected.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,